@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NBCDXSPB-2 mesh:pharmacologicalAction jvr:-TKJ6KRDN-X .
jvr:-ZB2RQRF8-B mesh:pharmacologicalAction jvr:-TKJ6KRDN-X .
jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CVGP4GCW-J
  skos:prefLabel "Ganglionic Stimulants"@en, "Gangliostimulants"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-TKJ6KRDN-X .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-B940GWB8-J
  skos:prefLabel "Agonistes cholinergiques"@fr, "Cholinergic Agonists"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-TKJ6KRDN-X .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-DZ46N4FF-5 mesh:pharmacologicalAction jvr:-TKJ6KRDN-X .
jvr:-LC0K6XB1-S mesh:pharmacologicalAction jvr:-TKJ6KRDN-X .
jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-JKJQHMML-Q mesh:pharmacologicalAction jvr:-TKJ6KRDN-X .
jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TKJ6KRDN-X
  mesh:allowableQualifier jvr:-D0F21513-5, jvr:-CB30NGKB-3, jvr:-W6SQV79N-S, jvr:-TJHVZCRZ-0, jvr:-WK5F724J-1, jvr:-NB0XHT3S-N, jvr:-NHL3D2X0-S, jvr:-BT300B3G-Q, jvr:-XV06LPML-W, jvr:-H7K65Q8S-Z, jvr:-NFTHND7Q-8, jvr:-THHNVC7V-3, jvr:-NKM836P1-M, jvr:-Q3979798-W, jvr:-S0CS1X5R-5, jvr:-G30ZJ446-J, jvr:-L6C0XPHT-4, jvr:-HQRFT0C6-B, jvr:-T9HQD7ST-J, jvr:-R3QWLHRG-V, jvr:-SBNWSM1T-R, jvr:-FWD2BGQ0-9 ;
  skos:broader jvr:-B940GWB8-J ;
  skos:prefLabel "Nicotinic Agonists"@en, "Agonistes nicotiniques"@fr ;
  skos:altLabel "Cholinergic Agonist, Nicotinic"@en, "Nicotinic Agonist"@en, "Agoniste nicotinique"@fr, "Agonistes cholinergiques nicotiniques"@fr, "Cholinergic Agonists, Nicotinic"@en ;
  skos:inScheme jvr: ;
  dc:created "1994-06-01"^^xsd:date ;
  dc:modified "2014-06-13"^^xsd:date ;
  a skos:Concept, mesh:Descriptor ;
  dc:established "1995-01-01"^^xsd:date ;
  skos:definition "Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission."@en ;
  skos:related jvr:-CVGP4GCW-J ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D018722> .